---
$id: https://graph.org.ai/products/commodity/51271702
$type: Product
source: UNSPSC
code: "51271702"
title: "Sodium oxybate"
class: "51271700"
classTitle: "Anaesthetic amidines and benzofurans and butyrates and cinnamates"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Sodium oxybate

**UNSPSC Code**: 51271702
**Class**: [Anaesthetic amidines and benzofurans and butyrates and cinnamates](Anaesthetic amidines and benzofurans and butyrates and cinnamates.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthesia adjuvant with the molecular formula C4H7O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7G33012534, chemically known as gamma-hydroxybutyric acid, sodium salt but generally known as sodium oxybate, which bears US NIH Compound Identifier 10412. European Medicines Agency schedules Sodium oxybate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14731MIG. World Health Organization schedules sodium oxybate in its Anatomical Therapeutic Chemical (ATC) Classification. As of Q4 2014, SODIUM OXYBATE remains the US FDA Preferred Term for this commodity. Sodium oxybate bears US NLM identifiers UMLS ID C0037537 and NCI Concept Code C61870. SMILES: C(CC(=O)[O-])CO.[Na+].

